H100 Group (H100) H1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
H1 25/26 earnings summary
19 Nov, 2025Executive summary
Net sales for the period May 1–September 30, 2025, reached 5.1 MSEK, up from 1.2 MSEK year-over-year.
Operating loss (EBIT) was -12.3 MSEK, with 7 MSEK in depreciation; loss after financial items was -38.0 MSEK, mainly due to non-cash items.
Rapid accumulation of Bitcoin holdings, reaching 1,046 BTC by September 30, 2025, funded by over SEK 1.1 billion in new capital.
Strategic focus on maximizing Bitcoin exposure per share and advancing digital health business.
Financial highlights
Net sales increased to 5.1 MSEK from 1.2 MSEK year-over-year.
Operating loss (EBIT) was -12.3 MSEK, compared to -1.5 MSEK last year.
Loss after financial items was -38.0 MSEK, with 32.7 MSEK from non-cash items.
Earnings per share was -0.12 SEK, compared to -0.09 SEK last year.
Solvency ratio at 71%, down from 95% year-over-year.
Outlook and guidance
Plans to continue growing Bitcoin treasury, enhance liquidity, and introduce BTC-denominated financial instruments.
Health-tech division to pursue platform advancement and strategic partnerships.
Latest events from H100 Group
- Strategic shift to Bitcoin treasury drove rapid asset growth but resulted in large non-cash losses.H100
H2 25/2624 Feb 2026 - Scalable health tech platform leverages influencer networks for rapid, recurring global growth.H100
Status Update23 Nov 2025 - Accelerating Bitcoin Treasury and global health initiatives to empower sovereign individuals.H100
Status Update21 Nov 2025 - Revenue up 166%, net loss reduced, and strategic shift to digital health acquisition underway.H100
H1 24/2513 Jun 2025 - Annual loss deepened on portfolio write-downs; net asset value per share fell 22%.H100
H2 23/2413 Jun 2025 - Acquisition-driven transformation and capital infusion position H100 for digital health growth.H100
H2 24/2511 Jun 2025